SCHEMBL4496523

SCHEMBL4496523

COc1c(C)c(C(=O)c2ccc(N)c(C(=O)O)c2)n2cccc(OCC(=O)NCCCCCCCCCCCNC(=O)COc3cccn4c(C(=O)c5ccc(N)c(C(=O)O)c5)c(C)c(OC)c34)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSD P07339 1/20 0.39
▸ DHODH Q02127 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ HDAC3 O15379 3/20 0.34
▸ HDAC1 Q13547 3/20 0.34
▸ TSHR P16473 1/20 0.34
▸ TUBB4A P04350 1/20 0.34
▸ TUBB P07437 1/20 0.34
▸ TUBA3C P0DPH7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4508358 0.93 CTSD (0.39) CTSDDHODHHSD17B10L3MBTL1ALDH1A1
SCHEMBL4508361 0.86 L3MBTL1 (0.38) CTSDDHODHHSD17B10L3MBTL1ALDH1A1
SCHEMBL13918689 0.86 MAPT (0.38) HSD17B10ALDH1A1KMT2AMAPTMEN1
SCHEMBL4496071 0.84 KMT2A (0.38) HSD17B10L3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL4507727 0.84 PLA2G1B (0.40) CTSDHSD17B10ALDH1A1KMT2AMAPT
SCHEMBL1573301 0.84 KMT2A (0.38) HSD17B10L3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL1572906 0.83 DDB1 (0.36) HSD17B10ALDH1A1KMT2AMAPTMEN1
SCHEMBL1572836 0.83 RXRA (0.41) ALDH1A1KMT2AMAPTMEN1HDAC1
SCHEMBL13918690 0.80 MEN1 (0.38) HSD17B10ALDH1A1KMT2AMAPTMEN1
SCHEMBL1572736 0.80 KMT2A (0.35) HSD17B10L3MBTL1ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 CTSD 1486/4885DHODH 4103/4885HSD17B10 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback